UBS Group AG Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on November 11, 2015, discloses the Basel III Pillar 3 regulatory capital position for UBS Group AG as of September 30, 2015. The filing reconciles the IFRS balance sheet to the regulatory scope of consolidation required by the Basel Committee on Banking Supervision and FINMA. It details the composition of capital on a phase-in basis.
Key Financial Metrics
The filing focuses on regulatory capital and balance sheet reconciliation rather than operating income statements. Key figures as of September 30, 2015, include:
- Total Assets (Regulatory Scope): CHF 962,322 million
- Total Liabilities (Regulatory Scope): CHF 906,374 million
- Total Equity (Regulatory Scope): CHF 55,949 million
- Common Equity Tier 1 (CET1) Capital: CHF 40,488 million
- Additional Tier 1 (AT1) Capital: CHF 3,638 million
- Tier 2 Capital: CHF 12,781 million
- Total Capital: CHF 56,906 million
- Total Risk-Weighted Assets: CHF 220,755 million
Capital Ratios:
- CET1 Ratio: 18.3%
- Tier 1 Ratio: 20.0%
- Total Capital Ratio: 25.8%
Debt and Liquidity: The filing lists "Debt issued" at CHF 102,715 million (regulatory scope) and "Due to customers" at CHF 385,846 million. Specific cash flow metrics are not provided in this regulatory disclosure.
Material Changes and Regulatory Adjustments
The filing highlights significant adjustments between IFRS accounting and regulatory capital calculations:
- Regulatory Adjustments to CET1: Total deductions amounted to CHF 13,503 million. Major components included goodwill (CHF 2,573 million), deferred tax assets recognized for tax loss carry-forwards (CHF 2,602 million), and unrealized losses from cash flow hedges (CHF 2,056 million).
- Phase-in Arrangements: The document notes the effect of transition phases, particularly regarding deferred tax assets arising from temporary differences (CHF 667 million deduction) and goodwill net of tax (CHF 3,859 million impact on AT1).
- Balance Sheet Reconciliation: Total assets under the regulatory scope (CHF 962,322 million) were lower than the IFRS scope (CHF 979,746 million) primarily due to the deconsolidation of certain entities for regulatory purposes.
Guidance, Outlook, and Risks
This filing is a regulatory capital disclosure and does not contain management commentary, forward-looking guidance, or specific risk factors regarding future business performance. It references the "Capital management" section of the third quarter 2015 report for details on phase-in arrangements. The filing confirms that UBS meets its capital requirements, with a CET1 ratio of 18.3% significantly exceeding the required 7.5% (including buffers).
Investor Verification Checklist
- Verify the reconciliation between IFRS equity (CHF 56,034 million) and regulatory CET1 capital (CHF 40,488 million) to understand the impact of regulatory deductions.
- Review the "Capital management" section of the Q3 2015 report for context on the phase-in arrangements affecting capital ratios.
- Confirm the composition of Tier 2 capital, specifically the CHF 10,198 million in low-trigger loss-absorbing capital.
- Check the "Deferred Contingent Capital Plan (DCCP)" details referenced in the footnotes regarding the CHF 908 million eligible for high-trigger loss-absorbing capital.
- Compare these regulatory capital figures with the bank's total risk-weighted assets to assess capital adequacy buffers.